REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Novo Nordisk Pharma" Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising, Public Relations, and Related Services | Convention and Trade Show Organizers | All Other Miscellaneous Schools and Instruction
Full name: "Novo Nordisk Pharma" Sp. z o.o. Profile Updated: February 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Novo Nordisk Pharma Ltd. is a pharmaceutical company, a global leader in caring for people with diabetes. The company manufactures and supplies the market for pharmaceutical products and services that have a significant impact on the lives of patients.

Headquarters
Ul. Krakowiakow 46
Warsaw; Mazowieckie; Postal Code: 02-255

Contact Details: Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.

Website: http://www.novonordisk.pl

Basic Information
Total Employees:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Incorporation Date:
February 18, 2002
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after "Novo Nordisk Pharma" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
38.51%▲
Total operating revenue
38.94%▲
Operating profit (EBIT)
20.81%▲
EBITDA
20.4%▲
Net Profit (Loss) for the Period
-18.71%▼
Total assets
27.91%▲
Total equity
30.36%▲
Operating Profit Margin (ROS)
-0.9%▼
Net Profit Margin
-2.9%▼
Return on Equity (ROE)
-14.06%▼
Quick Ratio
0.02%▲
Cash Ratio
-0.15%▼

Similar companies

Selvita S.A.
 
Celon S.A.
Mabion S.A.
 
Sartorius Stedim Poland Sp. z o.o.
Polpharma Biologics S.A.
 
Ryvu Therapeutics S.A.
Inventionbio S.A.
 
Brass Research And Development Sp. z o.o.
Medicover Integrated Clinical Services Sp. z o.o.
 
Ekobenz Sp. z o.o.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo